WO2000006739A3 - Chlamydia antigens and corresponding dna fragments and uses thereof - Google Patents
Chlamydia antigens and corresponding dna fragments and uses thereof Download PDFInfo
- Publication number
- WO2000006739A3 WO2000006739A3 PCT/IB1999/001328 IB9901328W WO0006739A3 WO 2000006739 A3 WO2000006739 A3 WO 2000006739A3 IB 9901328 W IB9901328 W IB 9901328W WO 0006739 A3 WO0006739 A3 WO 0006739A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dna fragments
- corresponding dna
- chlamydia
- chlamydia antigens
- cpn100202
- Prior art date
Links
- 241000606161 Chlamydia Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 241001647372 Chlamydia pneumoniae Species 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- -1 DNA Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU47929/99A AU4792999A (en) | 1998-07-27 | 1999-07-27 | (chlamydia) antigens and corresponding dna fragments and uses thereof |
MXPA01001089A MXPA01001089A (en) | 1998-07-27 | 1999-07-27 | Chlamydia. |
JP2000562521A JP2002521059A (en) | 1998-07-27 | 1999-07-27 | Chlamydia antigens and corresponding DNA fragments and uses thereof |
CA002337092A CA2337092A1 (en) | 1998-07-27 | 1999-07-27 | Chlamydia antigens and corresponding dna fragments and uses thereof |
EP99931394A EP1144638A3 (en) | 1998-07-27 | 1999-07-27 | Chlamydia antigens and corresponding dna fragments and uses thereof |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9419898P | 1998-07-27 | 1998-07-27 | |
US60/094,198 | 1998-07-27 | ||
US36070799A | 1999-07-26 | 1999-07-26 | |
US09/360,707 | 1999-07-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000006739A2 WO2000006739A2 (en) | 2000-02-10 |
WO2000006739A3 true WO2000006739A3 (en) | 2001-08-16 |
Family
ID=56289927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1999/001328 WO2000006739A2 (en) | 1998-07-27 | 1999-07-27 | Chlamydia antigens and corresponding dna fragments and uses thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2000006739A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7807802B2 (en) | 2002-11-12 | 2010-10-05 | Abbott Lab | Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0784059A1 (en) * | 1994-09-20 | 1997-07-16 | Hitachi Chemical Co., Ltd. | Antigenic polypeptide of chlamydia pneumoniae |
WO1998002546A2 (en) * | 1996-07-12 | 1998-01-22 | University Of Manitoba | Dna immunization against chlamydia infection |
WO1999027105A2 (en) * | 1997-11-21 | 1999-06-03 | Genset | Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
-
1999
- 1999-07-27 WO PCT/IB1999/001328 patent/WO2000006739A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0784059A1 (en) * | 1994-09-20 | 1997-07-16 | Hitachi Chemical Co., Ltd. | Antigenic polypeptide of chlamydia pneumoniae |
WO1998002546A2 (en) * | 1996-07-12 | 1998-01-22 | University Of Manitoba | Dna immunization against chlamydia infection |
WO1999027105A2 (en) * | 1997-11-21 | 1999-06-03 | Genset | Chlamydia pneumoniae genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
Non-Patent Citations (3)
Title |
---|
BANNANTINE ET AL.: "Chlamydophila caviae strain GPIC amino acid transporter (Aaat), sodium-dependent transporter (NadT), inclusion membrane protein B (IncB), and inclusion membrane protein C (IncC) genes, complete cds, and unknown gene", EMBL DATABASE ACC NO AF017105, 13 September 1997 (1997-09-13), XP002127834 * |
BANNANTINE ET AL.: "Tandem genes of Chlamydia psittaci that encode proteins localized to the inclusion membrane", MOLECULAR MICROBIOLOGY, vol. 28, no. 5, June 1998 (1998-06-01), pages 1017 - 1026, XP000856853 * |
KALMAN ET AL.: "Chlamydia pneumoniae section 30 of 103 of the complete genome", EMBL DATABASE ACC NO AE001614, 15 March 1999 (1999-03-15), XP002127835 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000006739A2 (en) | 2000-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001046224A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2000066739A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
BR9712971A (en) | Method for producing a vaccine to protect a host against disease caused by a chlamydia chain and immunological composition | |
WO2001070174A3 (en) | Vegf-modulated genes and methods employing them | |
JP2002535956A5 (en) | ||
WO2001029222A3 (en) | Polypeptides having phospholipase b activity and nucleic acids encoding same | |
WO2001046225A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
ATE348892T1 (en) | CHLAMYDIA ANTIGENS, CORRESPONDING DNA FRAGMENTS AND THEIR USES | |
WO2001075111A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2002040668A3 (en) | Proteins and dna sequences underlying these proteins used for treating inflammations | |
WO2001075113A3 (en) | Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof | |
WO2001074863A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2001075112A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2001075114A3 (en) | Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof | |
EP2172214A3 (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof | |
WO2000006742A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2001098469A3 (en) | Polypeptides having peroxidase activity and nucleic acids encoding same | |
WO1999051745A3 (en) | Dna immunization against chlamydia infection | |
WO1999025829A3 (en) | Cdk2 protein and cdk2 protein complexes | |
WO2000026239A3 (en) | $i(chlamydia) antigens and corresponding dna fragments and uses thereof | |
WO2000011183A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2003012099A1 (en) | Chondroitin synthase | |
MXPA01004353A (en) | Chlamydia. | |
WO2001046226A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
WO2000006739A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2000 562521 Country of ref document: JP Kind code of ref document: A Ref document number: 2337092 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/001089 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 47929/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999931394 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 509948 Country of ref document: NZ |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWP | Wipo information: published in national office |
Ref document number: 1999931394 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999931394 Country of ref document: EP |